Volume 74, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


A large-scale study was undertaken to clarify the prevalence rate of strongyloidiasis in Okinawa, Japan and to evaluate the relationship between strongyloidiasis and infection with human T cell lymphotropic virus type 1 (HTLV-1). The prevalence rate of and HTLV-1 infection were 6.3% and 14.0%, respectively. Among 2,185 patients more than 50 years of age, the rate of infection was significantly higher in patients with HTLV-1 infection compared with patients without HTLV-1 infection. In 252 patients treated with ivermectin, serum IgE levels and peripheral eosinophil counts were significantly lower in HTLV-1 co-infected patients compared with patients without HTLV-1 infection. In addition, the anthelmintic effect was significantly lower in patients with HTLV-1 infection compared with patients without HTLV-1 infection. Our prospective study demonstrated a prevalence rate for strongyloidiasis and HTLV-1 infections, and clearly demonstrated that co-infection with HTLV-1 impaired the immune response against .


Article metrics loading...

Loading full text...

Full text loading...



  1. Nakada K, Kohakura M, Komoda H, Hinuma K, 1984. High incidence of HTLV antibody in carriers of Strongyloides stercoralis. Lancet 1 : 633.
  2. Robinson RD, Lindo JF, Neva FA, Gam AA, Vogel P, Terry SI, Cooper ES, 1994. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica. J Infect Dis 169 : 692–696.
  3. Carvalho EM, Porto A, 2004. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 26 : 487–497.
  4. Terashima A, Alvarez H, Tello R, Infante R, Freedman DO, Gotuzzo E, 2002. Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection. Int J Infect Dis 6 : 28–30.
  5. Sato Y, Shiroma Y, Kiyuna S, Toma H, Kobayashi J, 1993. Reduced effect of chemotherapy of strongyloidiasis in patients with concurrent HTLV-1 infection in Okinawa, Japan. Jpn J Trop Med Hyg 20 : 183–192.
  6. Satoh M, Toma H, Sato Y, Takara M, Shiroma Y, Kiyuna S, Hirayama K, 2002. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1. Clin Exp Immunol 127 : 354–359.
  7. Gotuzzo E, Terashima A, Alvarez H, Tello R, Infante R, Watts DM, Freedman DO, 1999. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg 60 : 146–149.
  8. Newton RC, Limpuangthip P, Greenberg S, Gam A, Neva FA, 1992. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. Am J Med 92 : 202–208.
  9. Porto AF, Neva FA, Bittencourt H, Lisboa W, Thompson R, Alcantara L, Carvalho EM, 2001. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 23 : 503–507.
  10. Neva FA, Filho JO, Gam AA, Thompson R, Freitas V, Melo A, Carvalho EM, 1998. Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. J Infect Dis 178 : 1856–1859.
  11. Fujino R, Kawato K, Ikeda M, Miyakoshi H, Mizukoshi M, Imai J, 1991. Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody. Jpn J Cancer Res 82 : 367–370.
  12. Arakaki T, Iwanaga M, Kinjo F, Saito A, Asato R, Ikeshiro T, 1990. Efficacy of agar-plate culture in detection of Strongyloides stercoralis infection. J Parasitol 76 : 425–428.
  13. Hayashi J, Kishihara Y, Yoshimura E, Furusyo N, Yamaji K, Kawakami Y, Murakami H, Kashiwagi S, 1997. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan. Am J Trop Med Hyg 56 : 71–75.
  14. Walzer PD, Milder JE, Banwell JG, Kilgore G, Klein M, Parker R, 1982. Epidemiologic features of Strongyloides stercoralis infection in an endemic area of the United States. Am J Trop Med Hyg 31 : 313–319.
  15. Matsuoka M, 2003. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 22 : 5131–5140.
  16. Zaha O, Hirata T, Uchima N, Kinjo F, Saito A, 2004. Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody. J Infect Chemother 10 : 348–351.
  17. Santos SB, Porto AF, Muniz AL, Jesus AR, Carvalho EM, 2004. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 4 : 7.
  18. Medhat A, Shehata M, Bucci K, Mohamed S, Dief AD, Badary S, Galal H, Nafeh M, King CL, 1988. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis 178 : 512–519.

Data & Media loading...

  • Received : 04 Aug 2005
  • Accepted : 09 Oct 2005

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error